Companies: 10,795·Total market cap: $144.5T
Lunai Bioworks Inc.

Lunai Bioworks Inc.

RENBNASDAQHealthcare
$1.42
+$0.00(+0.00%)
Market Cap$32915951
P/E Ratio—
52W High$21
52W Low$1.1208
SEC Filings

Lunai Bioworks Inc. (RENB) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001527728 · RENB · NASDAQ · as of Jun 9, 2026

Filing snapshot

586
Total Filings
8-K
Latest Form
2026-05-20
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001527728 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-09-29
Fiscal Year End
Sep 29, 2025
Accession No.
0001731122-25-001316
Primary Document
e6882_10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001527728 · Accession 0001731122-25-001316

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2026-05-15
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-05-20Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2026-05-20
View
10-QQuarterly Report
FORM 10-Q
2026-05-15
View
8-KCurrent Report
FORM 8-K
2026-05-13
View
8-K/ACurrent Report (Amended)
FORM 8-K/A
2026-05-11
View
DEFR14ADEFR14A
FORM DEFR14A
2026-05-01
View
8-KCurrent Report
FORM 8-K
2026-05-01
View
8-KCurrent Report
FORM 8-K
2026-04-28
View
DEFA14AProxy Statement (Additional)
FORM DEFA14A
2026-04-28
View
DEFR14ADEFR14A
FORM DEFR14A
2026-04-15
View
DEF 14AProxy Statement
FORM DEF 14A
2026-04-13
View
PRE 14APRE 14A
FORM PRE 14A
2026-04-02
View
8-KCurrent Report
FORM 8-K
2026-03-30
View
8-KCurrent Report
FORM 8-K
2026-03-05
View
8-KCurrent Report
FORM 8-K
2026-02-23
View
10-QQuarterly Report
FORM 10-Q
2026-02-17
View
Showing 1–15 of 457 filingsForm 4 / 144 hidden· 586 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001527728  |  Exchange: NASDAQ · Healthcare

Lunai Bioworks Inc. (NASDAQ: RENB) has submitted 586 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001527728, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Lunai Bioworks Inc.'s most comprehensive regulatory disclosure. The most recent Lunai Bioworks Inc. 10-K was filed on 2025-09-29 for fiscal year ending 2025. Historical RENB 10-K annual reports are available from 2011 through 2025.

Investors researching Lunai Bioworks Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ORKA SEC Filings →IRD SEC Filings →STSA SEC Filings →GRCE SEC Filings →MRNS SEC Filings →ANGN SEC Filings →ALLK SEC Filings →FRLN SEC Filings →
→ RENB Financials→ RENB Earnings→ RENB Insider Trades

Frequently Asked Questions

RENB SEC Filings · 8 questions

Lunai Bioworks Inc. (RENB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 586 filings and access original documents at no cost. Lunai Bioworks Inc.'s CIK is 0001527728.

RENB SEC filingsLunai Bioworks Inc. SEC documentsfind RENB 10-K